GlaxoSmithKline making $139M investment in Rockville plant

British drug giant GlaxoSmithKline PLC (NYSE: GSK) is investing $139 million to expand its Rockville manufacturing site, saying it needs extra capacity there to meet anticipated demand for its lupus drug. The expansion would allow the company to boost bulk production of a substance used in several of its drugs, including Benlysta, by about 50 percent. The expansion comes as the pharmaceutical giant is awaiting Food and Drug Administration approval to sell a new self-injectable form of Benlysta.…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news